 |
 |
| Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
| JR6-L2707 |
 |
(R)-1-(3-chloro-2-fluorophenyl)propan-2-ol |
96%
|
$680/1g, $2980/5g |
Delete |
| JR6-L3145 |
 |
[1,1'-Binaphthalen]-2-ol, 2'-methoxy-3-methyl-, (1S)- |
96%
|
|
Delete |
| JR6-L3062 |
 |
1,2-Benzisothiazole, 3-(1-methyl-4-piperidinyl)- |
96%
|
|
Delete |
| JR6-L7431 |
 |
1,2-Propanediol, 3-(3-fluoro-1',2',3',6'-tetrahydro[2,4'-bipyridin]-5-yl)-, (2S)- |
96%
|
|
Delete |
| JR6-L3731 |
 |
1H-Imidazole-2-ethanol, a-methyl-1-(triphenylmethyl)-, (aS)- |
96%
|
|
Delete |
| JR6-L7976 |
 |
1H-Indole-3-carboxylic acid, 3-amino-5-chloro-2,3-dihydro-2-oxo-, (3S)- |
96%
|
|
Delete |
| A1-0710 |
 |
2-(4-Hydroxymethylphenyl)pyridine |
98%
|
POA |
Delete |
| AS-7132 |
 |
2-Acetylamino-4-methylpyridine |
98%
|
|
Delete |
| JR6-L3922 |
 |
2-Pyrrolidinemethanol, a,a-bis[4-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl)phenyl]-, (2S)- |
96%
|
$680/10mg, $1080/20mg, $1680/50mg, $2580/100mg |
Delete |
| JR6-L6891 |
 |
3-CYCLOHEXYLPROPYL BROMIDE |
96%
|
|
Delete |
| A1-1143 |
 |
3-Isopropylphenylboronic acid |
98%
|
5g/$17525g/525 |
Delete |
| JR6-L7424 |
 |
3-Pyridineethanol, a-methyl-2-(4-morpholinyl)-, (aR)- |
96%
|
|
Delete |
| AS-2059 |
 |
5-Bromo-2-methoxybenzoic acid |
98%
|
|
Delete |
| JR6-L5697 |
 |
Benzenesulfonic acid, 4-chloro-, 3-butyn-1-yl ester |
96%
|
|
Delete |
| JR6-L7809 |
 |
Benzonitrile, 4-(2S)-2-oxiranyl- |
96%
|
|
Delete |
| AS-7235 |
 |
D-Pyroglutamic acid |
98%
|
|
Delete |
| AS-7092 |
 |
Metolazone |
98%
|
|
Delete |
| A1-0140 |
 |
N-1-Boc-3-Ethylpiperazine |
>96%
|
$48/1g, $168/5g, $518/25g |
Delete |
| AS-8019 |
 |
N-BUTYL METHANESULPHONATE |
98%
|
|
Delete |
| AS-5590 |
 |
Perfluorooctyl iodide |
98%
|
|
Delete |
| JR8-N1248 |
 |
Physcion 1-O-beta-D-glucoside |
98% (HPLC)
|
$198/5mg, $398/10mg, $598/25mg, 100mg |
Delete |
| JR6-L4643 |
 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-8-hydroxy-4-oxo-, 1,1-dimethylethyl ester |
96%
|
|
Delete |
|
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |